Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.

Authors

Gelfond J, Al-Bayati O, Kabra A, Iffrig K, Kaushik D, Liss MA

Affiliations

  • Department of Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX.
  • Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX.
  • Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX; Department of Surgery, South Texas Veterans Healthcare System, San Antonio, TX. Electronic address: Liss@uthscsa.edu.

Abstract

INTRODUCTION: Identify modifiable factors contributing to renal cell carcinoma in the PCLO to target disease prevention and reduce health care costs.

METHODS: The prostate, lung, colorectal, and ovarian database were queried for the primary outcome of kidney cancer. Demographics were investigated, specifically focusing on modifiable risk factors. Statistical analysis includes the Student t-test for continuous variables, chi-squared or Fisher's exact tests for dichotomous and categorical variables for bivariate analysis. The Cox proportional hazards model was used in a multivariate time-to-event analysis.

RESULTS: We investigate existing data relating specifically to renal cancer. After missing data were excluded, we analyzed 149,683 subjects enrolled in the prostate, lung, colorectal, and ovarian trial and noted 0.5% (n = 748) subjects developed renal cancer. Age, male gender, body mass index, diabetes, and hypertension were all significant associated with renal cancer in bivariate analysis (P<0.05). Men have a significant increased risk of kidney cancer over women (hazard ratio [HR] = 1.85; 95% CI: 1.58-2.16; P<0.0001). Nonmodifiable risk factors that are associated with kidney cancer include age (HR = 1.05; 95% CI: 1.01; 1.05, P = 0.001). Modifiable risk factors include obesity measured by body mass index (HR = 1.05; 95% CI: 1.02-1.07; P<0.0001), hypertension (HR = 1.32; 95% CI: 1.13-1.54; P = 0.0004), and smoking in pack-years (HR = 1.04; 95% CI: 1.02-1.07; P = 0.0002).

CONCLUSIONS: Obesity, hypertension, and smoking are the 3 modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma.

Publication Details

PubMed ID
29779672

Publication
Urol. Oncol. 2018 Jul; Volume 36 (Issue 7): Pages 340.e1-340.e6

Related CDAS Studies Related CDAS Studies